SK1602000A3 - NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FORì (54) THE TREATMENT OF ARTHRITIS - Google Patents
NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FORì (54) THE TREATMENT OF ARTHRITIS Download PDFInfo
- Publication number
- SK1602000A3 SK1602000A3 SK160-2000A SK1602000A SK1602000A3 SK 1602000 A3 SK1602000 A3 SK 1602000A3 SK 1602000 A SK1602000 A SK 1602000A SK 1602000 A3 SK1602000 A3 SK 1602000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- hydroxy
- indanyl
- methyl
- absent
- phenyl
- Prior art date
Links
- 0 C*([C@]([C@@](C1)O)(c2c1cccc2)I)C(C(C*)[C@](*)C(N)=O)=I Chemical compound C*([C@]([C@@](C1)O)(c2c1cccc2)I)C(C(C*)[C@](*)C(N)=O)=I 0.000 description 9
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5594497P | 1997-08-18 | 1997-08-18 | |
US6833597P | 1997-12-19 | 1997-12-19 | |
PCT/US1998/017048 WO1999009000A2 (en) | 1997-08-18 | 1998-08-18 | Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
SK1602000A3 true SK1602000A3 (en) | 2000-09-12 |
Family
ID=26734798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK160-2000A SK1602000A3 (en) | 1997-08-18 | 1998-08-18 | NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FORì (54) THE TREATMENT OF ARTHRITIS |
Country Status (15)
Country | Link |
---|---|
US (1) | US6576664B1 (xx) |
EP (1) | EP1005448A2 (xx) |
KR (1) | KR20010023001A (xx) |
CN (1) | CN1268117A (xx) |
AR (1) | AR016134A1 (xx) |
AU (1) | AU9021498A (xx) |
BR (1) | BR9815596A (xx) |
CA (1) | CA2301038A1 (xx) |
EE (1) | EE200000093A (xx) |
HR (1) | HRP980443A2 (xx) |
IL (1) | IL133952A0 (xx) |
NO (1) | NO20000784L (xx) |
PL (1) | PL339006A1 (xx) |
SK (1) | SK1602000A3 (xx) |
WO (1) | WO1999009000A2 (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6747027B1 (en) | 1996-07-22 | 2004-06-08 | Pharmacia Corporation | Thiol sulfonamide metalloprotease inhibitors |
US7115632B1 (en) | 1999-05-12 | 2006-10-03 | G. D. Searle & Co. | Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
US6696449B2 (en) | 1997-03-04 | 2004-02-24 | Pharmacia Corporation | Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
US6794511B2 (en) | 1997-03-04 | 2004-09-21 | G. D. Searle | Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
US20010039287A1 (en) | 1997-11-14 | 2001-11-08 | Thomas E Barta | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
RU2250105C2 (ru) | 1997-11-14 | 2005-04-20 | Дж.Д.Сёрл ЛЛС | Ароматическая сульфонгидроксамовая кислота в качестве ингибитора металлопротеаз |
US6750228B1 (en) | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
US6800646B1 (en) | 1999-02-08 | 2004-10-05 | Pharmacia Corporation | Sulfamato hydroxamic acid metalloprotease inhibitor |
CA2361848A1 (en) * | 1999-04-02 | 2000-10-12 | Dupont Pharmaceuticals Company | Novel lactam inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase |
US6649377B1 (en) | 1999-05-10 | 2003-11-18 | Syntex (U.S.A.) Llc | Human aggrecanase and nucleic acid compositions encoding the same |
US6656448B1 (en) * | 2000-02-15 | 2003-12-02 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
US6683093B2 (en) | 2000-05-12 | 2004-01-27 | Pharmacia Corporation | Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
EA200301116A1 (ru) | 2001-05-11 | 2004-06-24 | Фармация Корпорейшн | Гидроксаматы ароматических сульфонов и их применение в качестве ингибиторов протеаз |
US6683078B2 (en) | 2001-07-19 | 2004-01-27 | Pharmacia Corporation | Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
JP2005537228A (ja) | 2002-04-25 | 2005-12-08 | ファルマシア・コーポレーション | ピペリジニル−及びピペラジニル−スルホニルメチルヒドロキサム酸並びにプロテアーゼ阻害剤としてのその使用 |
WO2004053103A2 (en) * | 2002-12-11 | 2004-06-24 | University Of Massachusetts | METHOD OF INTRODUCING siRNA INTO ADIPOCYTES |
CN1901971A (zh) * | 2003-12-15 | 2007-01-24 | 日本烟草产业株式会社 | 环丙烷化合物及其药物应用 |
US20060281699A1 (en) * | 2004-05-12 | 2006-12-14 | Merchiers Pascal G | Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
JP2009527568A (ja) * | 2006-02-22 | 2009-07-30 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体の調節剤 |
EA017308B1 (ru) * | 2007-05-10 | 2012-11-30 | Олбани Молекьюлар Рисерч, Инк. | Арилокси- и гетероарилоксизамещенные тетрагидробензазепины и их применение для блокировки обратного захвата норэпинефрина, допамина и серотонина |
EA019511B1 (ru) * | 2009-05-28 | 2014-04-30 | Новартис Аг | Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина |
WO2013070471A1 (en) | 2011-11-11 | 2013-05-16 | Lantheus Medical Imaging, Inc. | Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
KR101829290B1 (ko) * | 2014-12-24 | 2018-02-19 | 주식회사 엘지화학 | Gpr120 효능제로서의 바이아릴 유도체 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8827308D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB9102635D0 (en) | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
EP0586537A4 (en) | 1991-05-28 | 1997-06-25 | Merck & Co Inc | Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
US5318964A (en) | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
GB2268935B (en) | 1992-06-24 | 1996-10-23 | Nat Heart & Lung Inst | Diagnosis of rejection of transplanted organs |
GB9215665D0 (en) | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9307956D0 (en) | 1993-04-17 | 1993-06-02 | Walls Alan J | Hydroxamic acid derivatives |
GB9320660D0 (en) | 1993-10-07 | 1993-11-24 | British Bio Technology | Inhibition of cytokine production |
US5508404A (en) * | 1995-03-15 | 1996-04-16 | Merck & Co., Inc. | Reductive amination process |
US6008243A (en) * | 1996-10-24 | 1999-12-28 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use |
-
1998
- 1998-08-14 US US09/134,484 patent/US6576664B1/en not_active Expired - Lifetime
- 1998-08-14 HR HR60/068,335A patent/HRP980443A2/hr not_active Application Discontinuation
- 1998-08-18 IL IL13395298A patent/IL133952A0/xx unknown
- 1998-08-18 SK SK160-2000A patent/SK1602000A3/sk unknown
- 1998-08-18 AU AU90214/98A patent/AU9021498A/en not_active Abandoned
- 1998-08-18 CN CN98807928A patent/CN1268117A/zh active Pending
- 1998-08-18 PL PL98339006A patent/PL339006A1/xx unknown
- 1998-08-18 BR BR9815596-2A patent/BR9815596A/pt not_active IP Right Cessation
- 1998-08-18 EP EP98942083A patent/EP1005448A2/en not_active Withdrawn
- 1998-08-18 EE EEP200000093A patent/EE200000093A/xx unknown
- 1998-08-18 CA CA002301038A patent/CA2301038A1/en not_active Abandoned
- 1998-08-18 KR KR1020007001609A patent/KR20010023001A/ko not_active Application Discontinuation
- 1998-08-18 AR ARP980104071A patent/AR016134A1/es not_active Application Discontinuation
- 1998-08-18 WO PCT/US1998/017048 patent/WO1999009000A2/en not_active Application Discontinuation
-
2000
- 2000-02-17 NO NO20000784A patent/NO20000784L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO20000784L (no) | 2000-04-07 |
WO1999009000A2 (en) | 1999-02-25 |
BR9815596A (pt) | 2001-01-02 |
CN1268117A (zh) | 2000-09-27 |
WO1999009000A3 (en) | 1999-09-10 |
EP1005448A2 (en) | 2000-06-07 |
IL133952A0 (en) | 2001-04-30 |
AR016134A1 (es) | 2001-06-20 |
CA2301038A1 (en) | 1999-02-25 |
NO20000784D0 (no) | 2000-02-17 |
KR20010023001A (ko) | 2001-03-26 |
PL339006A1 (en) | 2000-12-04 |
US6576664B1 (en) | 2003-06-10 |
AU9021498A (en) | 1999-03-08 |
EE200000093A (et) | 2000-12-15 |
HRP980443A2 (en) | 1999-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK1602000A3 (en) | NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FORì (54) THE TREATMENT OF ARTHRITIS | |
JP2771328B2 (ja) | N―フェニルアルキル置換α―アミノカルボキシアミド誘導体およびその製造方法 | |
ES2277143T3 (es) | 2,5-dioxoimidazolidin-4-ilacetamidas y analogos como inhibidores de metaloproteinasa mmp12. | |
JP4177483B2 (ja) | スルホニルアミノカルボン酸 | |
CA2244912C (en) | Novel substituted cyclic amino acids as pharmaceutical agents | |
US5703092A (en) | Hydroxamic acid compounds as metalloprotease and TNF inhibitors | |
CA2122227A1 (en) | Peptide analogs as irreversible interleukin-1.beta. protease inhibitors | |
EP0474561A1 (fr) | Arylalkylamines, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
CA2330095A1 (en) | Substituted aryl hydroxamic acids as metalloproteinase inhibitors | |
JP2002541138A (ja) | マトリックスメタロプロテアーゼ、TNF−α、およびアグレカナーゼの阻害剤としての新規アミド誘導体 | |
FR2609716A1 (fr) | Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments | |
PT1554250E (pt) | Novas lactamas e suas utilizações | |
CA2359561A1 (en) | Proteasome inhibitors | |
HU208111B (en) | Process for producing phenol derivatives and pharmaceutical compositions comprising such compounds | |
CA2361848A1 (en) | Novel lactam inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase | |
RU2228330C2 (ru) | Омега-амиды n-арилсульфонил-аминокислот | |
US6620823B2 (en) | Lactam metalloprotease inhibitors | |
EP0465369B1 (fr) | Nouveaux dérivés N-substitués d'alpha-mercapto alkylamines, leur procédé de préparation et les intermédiaires obtenus, leur application à titre de médicaments et les compositions les renfermant | |
CA2330108A1 (en) | Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors | |
JP3231775B2 (ja) | 心循環器系に作用する2−アミノ−1,2,3,4−テトラヒドロナフタレン誘導体、それらを製造する方法、及びそれらを含む医薬組成物 | |
US4490386A (en) | Phosphate salts of 1-[2-[(1-alkoxycarbonyl-3-aralkyl)-amino]-1-oxoalkyl]octahydro-1H-indole-2-carboxylic acids, preparation of, and medical compositions thereof | |
JP2002513781A (ja) | メチオニンアミノペプチダーゼ−2の置換β−アミノ酸阻害剤 | |
WO1993022279A1 (fr) | Derives diamines ayant une affinite selective pour les recepteurs sigma | |
CZ2000371A3 (cs) | Nové inhibitory aggrekanázy a matricových metaloproteináz pro léčbu artritidy | |
HUT66944A (en) | Process for preparation of propylamine derivatives and pharmaceuticals containing them |